Bruker Corporation - Common Stock (BRKR)
Healthcare › Laboratory Analytical Instruments
Price History
Feb 9, 2026 — Jul 6, 2026Investment Snapshot
- Trading 1,459% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 3/9 — signs of financial weakness
- Loss-making — negative ROE of -0.8%
Bruker Corporation - Common Stock (BRKR) is a Healthcare company operating in Laboratory Analytical Instruments, listed on the NASDAQ , with a market capitalisation of $9.2 billion . Key value metrics: P/E ratio 1,461.2, P/B ratio 3.75, Piotroski F-Score 3 out of 9 .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Bruker Corporation - Common Stock — Fundamental Analysis Summary
Bruker Corporation - Common Stock (BRKR) is currently trading 1,459% above its Graham Number of $3.89, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 1,461.2x.
On financial health, BRKR shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and negative return on equity of -0.8% (sector average: -20.6%), and manageable leverage with a debt-to-equity ratio of 0.68.
StockPik's composite Value Score for BRKR is 40/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
BRKR reports a solid gross margin of 45.9% (sector average: 39.4%) and a modest operating margin of 0.1%.
BRKR shows revenue growing at 2% year-over-year, with earnings declining at 108%.
BRKR pays a modest dividend yield of 0.3%.